News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TopoTarget A/S Release: Positive Data From the BELIEF trial presented at the 2013 American Society of Clinical Oncology Annual Meeting


6/3/2013 10:05:21 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Topotarget today announced positive results from the BELIEF trial, a pivotal, single-arm study of belinostat in patients with relapsed or refractory peripheral T-cell lymphoma (R/R PTCL) after failure of =1 prior systemic therapies.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES